Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOP Injection in Iron Deficiency Anemia
NCT03485053Phase 2Terminated
- Sponsor
- MegaPro Biomedical
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MPB-1514 in iron deficiency anemia (IDA), sponsored by MegaPro Biomedical. Started Nov 2018; status: terminated.
02
Drugs
MPB-1514
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03485053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485053.